The absence of the dystrophin protein in Duchenne muscular dystrophy (DMD) results in
myofiber fragility and a plethora of downstream secondary pathologies. Although a variety of …

Duchenne muscular dystrophy (DMD) is caused by genetic deficiency of dystrophin and
characterized by massive structural and functional changes of skeletal muscle tissue …

ABSTRACT Purpose/Aim Duchenne muscular dystrophy (DMD) is a progressive
neuromuscular disease characterized by extensive muscle weakness. Patients with DMD …

Duchenne muscular dystrophy (DMD) is a genetic muscle wasting condition with limited
treatment options available and is caused by the lack of dystrophin. However …

Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy with
no cure currently available. In this study, using two microarray data sets obtained from the …

Serum biomarkers in Duchenne muscular dystrophy (DMD) may provide deeper insights
into disease pathogenesis, suggest new therapeutic approaches, serve as acute read-outs …

The primary cause of Duchenne muscular dystrophy (DMD) is a mutation in the dystrophin
gene, leading to absence of the corresponding protein, disruption of the dystrophin …

Mdx mice with a spontaneous mutation in exon 23 of the Dmd gene represent the most
common model to investigate the pathophysiology of Duchenne muscular dystrophy (DMD) …

In skeletal muscle, the dystrophin-glycoprotein complex forms a membrane-associated
assembly of relatively low abundance, making its detailed proteomic characterization in …

Background: Animal models of Duchenne muscular dystrophy (DMD) are essential to study
disease progression and assess efficacy of therapeutic intervention, however dystrophic …